Cardiovascular Journal of Africa: Vol 29 No 5 (September/October 2018)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 5, September/October 2018

320

AFRICA

Myasoedova E, Davis JM III, Crowson CS, Gabriel SE

Epidemiology of

rheumatoid arthritis: rheumatoid arthritis and mortality.

Curr Rheumatol

Rep

2010;

(5): 379–385.

Abasolo L, Ivorra-Cortes J, Leon L, Jover JA, Fernandez-Gutierrez B,

Rodriguez-Rodriguez L. Influence of demographic and clinical factors

on the mortality rate of a rheumatoid arthritis cohort: a 20-year survival

study.

Semin Arthritis Rheum

2016;

(5): 533–538.

Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W,

Symmons D,

et al.

Association of the

HLA-DRB1

gene with premature

death, particularly from cardiovascular disease, in patients with rheuma-

toid arthritis and inflammatory polyarthritis.

Arthritis Rheum

2008;

(2):

359–369.

10. Anderson R, Meyer PW, Ally MM, Tikly M

Smoking and air pollution

as pro-inflammatory triggers for the development of rheumatoid arthritis.

Nicotine Tob Res

2016;

(7): 1556–1565.

11. Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald

et al.

A new model for an etiology of rheumatoid arthritis: smoking may

trigger HLA-DR (shared epitope)-restricted immune reactions to autoan-

tigens modified by citrullination.

Arthritis Rheum

2006;

(1): 38–46.

12. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE

Cardiovascular death in rheumatoid arthritis: a population-based study.

Arthritis Rheum

2005;

(3): 722–732.

13. Targo

ska-St

pniak B, Drelich-Zbroja A, Majdan M. The relationship

between carotid intima-media thickness and the activity of rheumatoid

arthritis.

J Clin Rheumatol

2011;

(5): 249–255.

14. Puttevils D, De Vusser P, Geusens P, Dens J

Increased cardiovascular

risk in patients with rheumatoid arthritis: an overview.

Acta Cardiol

2014;

(2): 111–118.

15. Gkaliagkousi E, Gavriilaki E, Doumas M, Petidis K, Aslanidis S, Stella D

Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and

management.

J Clin Rheumatol

2012;

(8): 422–430.

16. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM,

Lacaille D

Risk of cardiovascular mortality in patients with rheumatoid

arthritis: a meta-analysis of observational studies.

Arthritis Rheum

2008;

(12): 1690–1697.

17. Steyers CM III, Miller FJ Jr. Endothelial dysfunction in chronic inflam-

matory diseases.

Int J Mol Sci

2014;

(7): 11324–11349.

18. Yang X, Chang Y, Wei W. Endothelial dysfunction and inflammation:

immunity in rheumatoid arthritis.

Mediators Inflamm

2016;

2016

: 6813016.

19. Ku IA, Imboden JB, Hsue PY, Ganz P. Rheumatoid arthritis: model of

systemic inflammation driving atherosclerosis.

Circ J

2009;

(6): 977–985.

20. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien

TK,

et al.

EULAR evidence-based recommendations for cardiovascular

risk management in patients with rheumatoid arthritis and other forms of

inflammatory arthritis.

Ann Rheum Dis

2010;

(2): 325–331.

21. Kievit W, Maurits JS, Arts EE, van Riel PL, Fransen J, Popa CD

Cost-

effectiveness of cardiovascular screening in patients with rheumatoid

arthritis.

Arthritis Care Res

2017;

(2): 175–182.

22. Liao KP. Cardiovascular disease in patients with rheumatoid arthri-

tis.

Trends Cardiovasc Med

2017;

(2): 136–140. doi: 10.1016/j.

tcm.2016.07.006

23. Martin-Martinez MA, González-Juanatey C, Castañeda S, Llorca J,

Ferraz-Amaro I, Fernández-Gutiérrez B,

et al.

Recommendations for the

management of cardiovascular risk in patients with rheumatoid arthritis:

scientific evidence and expert opinion.

Semin Arthritis Rheum

2014;

(1):

1–8.

24. Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed

Cardiovascular risk in rheumatoid arthritis: recent advances in the

understanding of the pivotal role of inflammation, risk predictors and the

impact of treatment.

Rheumatology

2014;

(12): 2143–2154.

25. Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R,

et al.

Clinical assessment of endothelial function in patients with rheuma-

toid arthritis: a meta-analysis of literature studies.

Eur J Intern Med

2015;

(10): 835–842.

26. Provan S, Angel K, Semb AG, Atar D, Kvien TK

NT-proBNP predicts

mortality in patients with rheumatoid arthritis: results from 10-year follow-

up of the EURIDISS study.

Ann Rheum Dis

2010;

(11): 1946–1950.

27. Mirjafari H, Welsh P, Verstappen SM, Wilson P, Marshall T, Edlin H,

et al.

N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and

mortality risk in early inflammatory polyarthritis: results from the Norfolk

Arthritis Registry (NOAR).

Ann Rheum Dis

2014;

(4): 684–690.

28. Avouac J, Meune C, Chenevier-Gobeaux C, Dieudé P, Borderie D, Lefevre

et al.

Inflammation and disease activity are associated with high circu-

lating cardiac markers in rheumatoid arthritis independently of traditional

cardiovascular risk factors.

J Rheumatol

2014;

(2): 248–255.

29. Beinsberger J, Heemskerk JW, Cosemans JM. Chronic arthritis and cardi-

ovascular disease: altered blood parameters give rise to a prothrombotic

propensity.

Semin Arthritis Rheum

2014;

(3): 345–352.

30. Meyer PW, Hodkinson B, Ally M, Musenge E, Wadee AA, Fickl H,

et al.

Circulating cytokine profiles and their relationships with autoantibodies,

acute phase reactants, and disease activity in patients with rheumatoid

arthritis.

Mediators Inflamm

2010;

2010

: 158514.

31. Dessein PH, Solomon A, Woodiwiss AJ, Norton GR, Tsang L, Gonzalez-

Gay MA

Marked independent relationship between circulating interleu-

kin-6 concentrations and endothelial activation in rheumatoid arthritis.

Mediators Inflamm

2013;

2013

: 510243.

32. Habets KL, Trouw LA, Levarht EW, Korporaal SJ, Habets PA, de Groot

et al.

Anti-citrullinated protein antibodies contribute to platelet activa-

tion in rheumatoid arthritis.

Arthritis Res Ther

2015;

: 209.

33. Florence JM, Krupa A, Booshehri LM, Allen TC, Kurdowska AK

Metalloproteinase-9 contributes to endothelial dysfunction in atheroscle-

rosis via protease activated receptor-1.

PLoS One

2017;

(2): e0171427.

34. Carestia A, Kaufman T, Rivadeneyra L, Landoni VI, Pozner RG,

Negrotto S,

et al.

Mediators and molecular pathways involved in the regu-

lation of neutrophil extracellular trap formation mediated by activated

platelets.

J Leukoc Biol

2016;

(1): 153–162.

35. Zhang Y, Guan L, Yu J, Zhao Z, Mao L, Li S,

et al.

Pulmonary endothelial

activation caused by extracellular histones contributes to neutrophil acti-

vation in acute respiratory distress syndrome.

Respir Res

2016;

(1): 155.

36. Stakos DA, Kambas K, Konstantinidis T, Mitroulis I, Apostolidou E,

Arelaki S,

et al.

Expression of functional tissue factor by neutrophil extra-

cellular traps in culprit artery of acute myocardial infarction.

Eur Heart J

2015;

(22): 1405–1414.

37. Dalbeni A, Giollo A, Tagetti A, Atanasio S, Orsolini G, Cioffi G,

et al.

Traditional cardiovascular risk factors or inflammation: which factors

accelerate atherosclerosis in arthritis patients?

Int J Cardiol

2017;

236

488–492.

38. Csordas A, Bernhard D. The biology behind the atherothrombotic effects

of cigarette smoke.

Nat Rev Cardiol

2013;

(4): 219–230.

39. Govind N, Ally MM, Tikly M, Anderson R, Hodkinson B, Meyer PW

Pitfalls in the assessment of smoking status detected in a cohort of South

African RA patients.

Rheumatol Int

2016;

(10): 1365–1369.

40. Siddiqi K, Shah S, Abbas SM, Vidyasagaran A, Jawad M, Dogar O,

et al.

Global burden of disease due to smokeless tobacco consumption in adults:

analysis of data from 113 countries.

BMC Med

2015;

: 194.

41. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D,

al.

Tobacco use and risk of myocardial infarction in 52 countries in the

INTERHEART study: a case-control study.

Lancet

2006;

368

(9536):

647–658.

42. Schweitzer KS, Chen SX, Law S, Van Demark M, Poirier C, Justice MJ,